Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × microcrystalline cellulose × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 1 Frailty 1

Interventions

pembrolizumab 513 Specimen Handling 404 Carboplatin 387 Magnetic Resonance Spectroscopy 371 Cisplatin 359 Cyclophosphamide 345 Radiotherapy 287 Gemcitabine 273 Bevacizumab 264 Paclitaxel 256 Biopsy 222 Drug Therapy 212 venetoclax 205 fludarabine 200 Capecitabine 199 Oxaliplatin 194 Nivolumab 194 Docetaxel 183 Injections 181 Fluorouracil 171 Dexamethasone 161 Radiosurgery 152 Rituximab 144 Pemetrexed 140 durvalumab 127 Standard of Care 127 atezolizumab 124 tislelizumab 121 Doxorubicin 116 Blood Specimen Collection 116

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡